Skip to content

Penumbra PEN Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Boston Scientific logo
Boston ScientificBSX

Other financials

Income statement

See full
Revenue$374.8M+15.6%
Gross profit$253.4M+17.4%
Operating income$38.2M-5.2%
Net income$32.6M-16.9%
EPS (diluted)$0.82-18.0%

Balance sheet

See full
Cash & equivalents$241.3M-35.8%
Total debt$216.2M-2.0%
Total equity$1.5B+21.5%
Total assets$1.9B+19.2%

Cash flow

See full
Operating cash flow$87.0M+77.6%
CapEx$13.7M+1.5%
Free cash flow$73.3M+106%

Valuation

See full
Market cap$12.48B+25.1%
Enterprise value$12.45B+26.8%
P/E72.9×-163×
P/S8.6×+0.5×

Profitability

See full
Gross margin67.4%+3.7pp
Operating margin12.9%+9.8pp
Net margin11.8%+8.4pp
FCF margin14.6%+2.5pp

Returns & leverage

See full
Return on equity12.7%+9.2pp
Debt / equity0.1×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Penumbra in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Penumbra’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Penumbra's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Penumbra's operating lease ROU assets?
Penumbra (PEN) reported operating lease ROU assets of $170.27M in Q1 2026.
How has Penumbra's operating lease ROU assets changed year-over-year?
Penumbra's operating lease ROU assets decreased by 2.9% year-over-year, from $175.33M to $170.27M.
What is the long-term trend for Penumbra's operating lease ROU assets?
Over 5 years (2020 to 2025), Penumbra's operating lease ROU assets has grown at a 33.3% compound annual growth rate (CAGR), from $41.19M to $173.59M.